UNSPSC 51172311: Activated carbon or activated charcoal for medical use

This classification denotes an element or isotope with the molecular formula C, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2P3VWU3H10, chemically known as 1,3-dichloro-propan-2-one but generally known as activated charcoal, which bears US NIH Compound Identifier 297. European Medicines Agency schedules Carbon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13242MIG. World Health Organization schedules activated charcoal in its Anatomical Therapeutic Chemical (ATC) Classification. SMILES: C.

UNSPSC 51172311 Activated carbon or activated charcoal for medical use is a Commodity code, but the only recent state and local opportunity tagged under it does not involve activated carbon or charcoal at all. Collin County Community Supervision and Corrections Department posted RFP 2026-327 on September 25, 2026 for offender specimen collection and drug testing services, spanning immunoassay screening, LC/MS/MS and GC/MS confirmation testing, oral fluid and hair testing methodologies, and electronic result reporting — none of which are activated carbon or charcoal products. The mismatch suggests either a tagging error in the source data or that this particular Commodity code sees little relevant recent state and local procurement activity.

The sole opportunity on record is a two-year contract (September 1, 2026 through August 31, 2028, with three optional one-year renewals to a five-year maximum) valued at approximately $600,000 annually, issued by Collin County in Texas. Collin County intends to award in whole or in part to one or more vendors and will evaluate proposals on vendor understanding (30 points), firm qualifications (25 points), client references (15 points), cost (30 points), and optional Phase 2 demonstrations and interviews (up to 30 additional points). The successful vendor must maintain lab certification from SAMHSA, TX DPS, or CAP and will service two collection sites in Plano and McKinney with approximately 25,031 tests annually across five-panel screens, six-panel screens, and ancillary testing. Pricing is per-test with three service models (screening only, confirmation after screening, and screening with automatic confirmation of positives), and all costs must include staffing and freight with no surcharges permitted. The anticipated award date was August 10, 2026.